Combined salmeterol and fluticasone for COPD.
Khamis
Ramzi Y
RY
Rajakulasingam
Raj K
RK
D000280:Administration, Inhalation; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000730:Androstadienes / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D018680:Cholinergic Antagonists / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D000068298:Fluticasone; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D000068299:Salmeterol Xinafoate; D013806:Theophylline / Q000008:administration & dosage; D014797:Vital Capacity
D000730:Androstadienes; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; D000068299:Salmeterol Xinafoate; D013806:Theophylline; D000068298:Fluticasone; D000420:Albuterol